Study of 500,000 people clarifies the risks of obesity

 

Bristol, UK (October 25, 2018) – Elevated body mass index (BMI) – a measure of weight accounting for a person’s height – has been shown to be a likely causal contributor to population patterns in mortality, according to a new study led by the University of Bristol using measurements and mortality data from 500,000 people. Specifically, for those in UK Biobank (a study of middle to late aged volunteers), every 5kg/m2 increase in BMI was associated with an increase of 16 per cent in the chance of death and 61 per cent for those related to cardiovascular diseases. The work is published today [Thursday 25 October] in Obesity Editors‘ Choice.

While it is already known that severe obesity increases the relative risk of death, previous studies have produced conflicting results with some appearing to suggest a protective effect at different parts of the spectrum of body mass index. Until now, no study has used a genetic-based approach to explore this link.

The Bristol team applied a method called Mendelian randomization, a technique that uses genetic variation in a person’s DNA to help understand the causal relationships between risk factors and health outcomes – here mortality. This method can provide a more accurate estimate of the effect of body mass index on mortality by removing confounding factors, for example, smoking, income and physical activity, and reverse causation (where people lose weight due to ill health), which could explain the conflicting findings in previous observational studies.

Using data from the UK Biobank, the team were able to show that the apparent optimum body mass index for survival was lower with Mendelian randomization analyses (within the normal weight rather than overweight range found with observational studies) and the association remained flatter over a larger range of body mass index.

The findings which link body mass index and mortality, confirm that being overweight increases a person’s risk of death from all causes including cardiovascular diseases and various cancers.

Dr Kaitlin Wade, Research Associate in Genetic Epidemiology at the Bristol Medical School (Population Health Studies) and lead author of the study, said: „The findings highlight the need for a global effort to reduce the surging levels of obesity within society and suggest that in most cases, any reduction in body mass index to a normal, healthy level is likely to be beneficial.“

 

This research was supported by the Wellcome Trust and included researchers associated with the Medical Research Council Integrative Epidemiology Unit, the Cancer Research UK Integrative Cancer Epidemiology Programme, the University of Bristol Population Health Sciences Institute and the University of Bristol NIHR Biomedical Research Centre.

Paper

  • ‚Body mass index and mortality in UK Biobank: revised estimates using Mendelian randomization‘ by K Wade et al in Obesity 

UNIVERSITY OF BRISTOL, 25.10.2018 (tB).

Schlagwörter:

MEDICAL NEWS

New guidance to prevent the tragedy of unrecognized esophageal intubation
Overly restrictive salt intake may worsen outcomes for common form…
COVID-19 vaccines are estimated to have prevanented 20 million deaths…
Novel sleep education learning modules developed for nurse practitioners
Scientists discover how salt in tumours could help diagnose and…

SCHMERZ PAINCARE

Aktuelle Versorgungssituation der Opioidtherapie im Fokus
Individuelle Schmerztherapie mit Opioiden: Patienten im Mittelpunkt
Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…

DIABETES

Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT
„Wissen was bei Diabetes zählt: Gesünder unter 7 PLUS“ gibt…
Kaltplasma bei diabetischem Fußsyndrom wirkt via Wachstumsfaktoren
Typ-1-Diabetes: InRange – auf die Zeit im Zielbereich kommt es…

ERNÄHRUNG

Gesunde Ernährung: „Nicht das Salz und nicht das Fett verteufeln“
Mangelernährung gefährdet den Behandlungserfolg — DGEM: Ernährungsscreening sollte zur klinischen…
Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?

ONKOLOGIE

Nahrungsergänzungsmittel während der Krebstherapie: Es braucht mehr Bewusstsein für mögliche…
Fusobakterien und Krebs
Fortgeschrittenes Zervixkarzinom: Pembrolizumab verlängert Leben
Krebspatienten unter Immuntherapie: Kein Hinweis auf erhöhtes Risiko für schwere…
Aktuelle Kongressdaten zum metastasierten Mammakarzinom und kolorektalen Karzinom sowie Neues…

MULTIPLE SKLEROSE

Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?
Neuer Therapieansatz für Multiple Sklerose und Alzheimer
„Ich messe meine Multiple Sklerose selbst!“ – Digitales Selbstmonitoring der…

PARKINSON

Alexa, bekomme ich Parkinson?
Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…